http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 20 Jul 2026 16:09:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html <p align="justify">SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the second quarter of 2026 after market close on Monday, August 3, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time</p> <p align="justify">Investors interested in listening to the conference call may do so by registering at this link: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=PV7N93LrKkb-Eg5GXKwMGieZ87KdP1NVErTmOQF_zUJcrfOvoLcNgqaTnfbqobM1BkgTrzHjjvohpUOLFGo7dj_PH40o-T1pzhQC2yzbdGFdggPpfJvICC2ELEl6a5UG366RR_pCI8FTOOntZyCzZ3lncYLbb9_Pz5-2YaX-mXA=" rel="nofollow" target="_blank">https://edge.media-server.com/mmc/p/4chyjb8g/</a>. Live audio of the webcast will be available http://www.streetinsider.com/Press+Releases/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html Mon, 20 Jul 2026 16:09:00 -0400 O.08190280 SIBN http://www.streetinsider.com/Press+Releases/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html <p align="justify">SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the second quarter of 2026 after market close on Monday, August 3, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time</p> <p align="justify">Investors interested in listening to the conference call may do so by registering at this link: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=PV7N93LrKkb-Eg5GXKwMGieZ87KdP1NVErTmOQF_zUJcrfOvoLcNgqaTnfbqobM1BkgTrzHjjvohpUOLFGo7dj_PH40o-T1pzhQC2yzbdGFdggPpfJvICC2ELEl6a5UG366RR_pCI8FTOOntZyCzZ3lncYLbb9_Pz5-2YaX-mXA=" rel="nofollow" target="_blank">https://edge.media-server.com/mmc/p/4chyjb8g/</a>. Live audio of the webcast will be available http://www.streetinsider.com/Press+Releases/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html Mon, 20 Jul 2026 16:09:00 -0400 O.08190280 SIBN http://www.streetinsider.com/Globe+Newswire/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html <p align="justify">SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the second quarter of 2026 after market close on Monday, August 3, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time</p> <p align="justify">Investors interested in listening to the conference call may do so by registering at this link: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=PV7N93LrKkb-Eg5GXKwMGieZ87KdP1NVErTmOQF_zUJcrfOvoLcNgqaTnfbqobM1BkgTrzHjjvohpUOLFGo7dj_PH40o-T1pzhQC2yzbdGFdggPpfJvICC2ELEl6a5UG366RR_pCI8FTOOntZyCzZ3lncYLbb9_Pz5-2YaX-mXA=" rel="nofollow" target="_blank">https://edge.media-server.com/mmc/p/4chyjb8g/</a>. Live audio of the webcast will be available http://www.streetinsider.com/Globe+Newswire/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html Mon, 20 Jul 2026 16:09:00 -0400 O.08190280 SIBN http://www.streetinsider.com/Globe+Newswire/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html <p align="justify">SANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the second quarter of 2026 after market close on Monday, August 3, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time</p> <p align="justify">Investors interested in listening to the conference call may do so by registering at this link: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=PV7N93LrKkb-Eg5GXKwMGieZ87KdP1NVErTmOQF_zUJcrfOvoLcNgqaTnfbqobM1BkgTrzHjjvohpUOLFGo7dj_PH40o-T1pzhQC2yzbdGFdggPpfJvICC2ELEl6a5UG366RR_pCI8FTOOntZyCzZ3lncYLbb9_Pz5-2YaX-mXA=" rel="nofollow" target="_blank">https://edge.media-server.com/mmc/p/4chyjb8g/</a>. Live audio of the webcast will be available http://www.streetinsider.com/Globe+Newswire/SI-BONE+To+Report+Second+Quarter+2026+Financial+Results+on+August+3%2C+2026/26789774.html Mon, 20 Jul 2026 16:09:00 -0400 O.08190280 SIBN http://www.streetinsider.com/Analyst+PT+Change/SI-BONE+Inc.+%28SIBN%29+PT+Raised+to+%2421+at+Truist+Securities/26776591.html Truist Securities analyst Richard Newitter raised the price target on SI-BONE Inc. (NASDAQ: SIBN) to $21.00 (from $18.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/SI-BONE+Inc.+%28SIBN%29+PT+Raised+to+%2421+at+Truist+Securities/26776591.html Thu, 16 Jul 2026 07:10:11 -0400 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Management+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html <p>ViCentra, a Dutch medical device company that makes the Kaleido insulin patch pump, has appointed Ian Wells as Chief Financial Officer and Thomas A. West as an Independent Board Director, according to a company statement.</p> <p>Wells, whose appointment took effect June 19, 2026, previously served as Global CFO of HOYA Vision Care, a $2.1 billion division of HOYA operating in more than 30 countries. He spent nearly two decades in finance roles within regulated medical technology.</p> <p>West joined the board July 1, 2026. He most recently served as President and CEO of Nalu Medical, which was acquired by Boston Scientific for $600 http://www.streetinsider.com/Board+Changes/ViCentra+names+new+CFO+and+adds+board+member+ahead+of+U.S.+expansion/26763709.html Tue, 14 Jul 2026 03:30:17 -0400 A.12740664 A.18341116 A.21849991 A.31449792 A.33173386 A.50216928 O.00004011 O.00038182 O.00330393 O.08190280 O.08403404 O.20331252 O.41041179 SIBN